1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NUDCD2 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA PSPC1 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA HNF1A CTRPv2 pan-cancer AAC 0.1 0.01
mRNA INTS12 CTRPv2 pan-cancer AAC -0.095 0.01
mRNA AGPAT4 CTRPv2 pan-cancer AAC -0.097 0.01
mRNA ZNF546 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA NEDD8-MDP1 CTRPv2 pan-cancer AAC -0.093 0.01
mRNA KDM3A CTRPv2 pan-cancer AAC 0.092 0.01
mRNA PEX7 CTRPv2 pan-cancer AAC 0.096 0.01
mRNA CNN3 CTRPv2 pan-cancer AAC -0.11 0.01
Download CSV